Literature DB >> 2886551

Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

J Lavoie, J F Giguère, G P Layrargues, R F Butterworth.   

Abstract

Brain tissue was obtained at autopsy from nine cirrhotic patients dying in hepatic coma and from an equal number of controls, free from neurological, psychiatric, or hepatic diseases, matched for age and time interval from death to freezing of dissected brain samples. Glutamine, glutamate, aspartate, and gamma-aminobutyric acid (GABA) levels were measured in homogenates of cerebral cortex (prefrontal and frontal), caudate nuclei, hypothalamus, cerebellum (cortex and vermis), and medulla oblongata as their o-phthalaldehyde derivatives by HPLC using fluorescence detection. Glutamine concentrations were found to be elevated two- to fourfold in all brain structures, the largest increases being observed in prefrontal cortex and medulla oblongata. Glutamate levels were selectively decreased in prefrontal cortex (by 20%), caudate nuclei (by 27%), and cerebellar vermis (by 17%) from cirrhotic patients. On the other hand, GABA content of autopsied brain tissue from these patients was found to be within normal limits in all brain structures. It is suggested that such region-selective reductions of glutamate may reflect loss of the amino acid from the releasable (neurotransmitter) pool. These findings may be of significance in the pathogenesis of hepatic encephalopathy resulting from chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886551     DOI: 10.1111/j.1471-4159.1987.tb00949.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  45 in total

Review 1.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 2.  Role of astrocytes in brain function and disease.

Authors:  Marta Sidoryk-Wegrzynowicz; Michal Wegrzynowicz; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

Review 3.  Neurochemistry of hepatic encephalopathy.

Authors:  C O Record
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

4.  Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy.

Authors:  G Therrien; R F Butterworth
Journal:  Metab Brain Dis       Date:  1991-06       Impact factor: 3.584

Review 5.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

6.  Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy.

Authors:  J Lavoie; J F Giguère; G P Layrargues; R F Butterworth
Journal:  Metab Brain Dis       Date:  1987-12       Impact factor: 3.584

Review 7.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 8.  New concepts in the mechanism of ammonia-induced astrocyte swelling.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao; K S Panickar
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 9.  The anaplerotic flux and ammonia detoxification in hepatic encephalopathy.

Authors:  Claudia Zwingmann
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

10.  L-glutamate and L-aspartate concentrations in the developing and aging human putamen tissue.

Authors:  M E Kornhuber; J Kornhuber; W Retz; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.